Analysis of anti-cancer chemicals and pharmaceutical formulations

Ended Awarded Last action

Contract number
HHSN261201700011I
Awardee
Awarding agency
Task orders
5 $133,865 obligated

Award facts

Opportunity
Combined order value
$133,865 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 3% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Stability studies of isotope-specific 2-ketoglutaric acid 75N91022F00001 National Cancer Institute (NIH) $48,980
The objective of this task order is to perform developmental studies of isotope-specific 2-ketoglutaric acid. 75N91021F00001 National Cancer Institute (NIH) $69,137
To# 2018-02; next z-endoxifen CT025-402-448-004 - API batch analysis milestone 4, analysis of anti-cancer chemical &… 75N91018F00003 National Cancer Institute (NIH) $7,307
Next z-endoxifen CT025-402-448-004 - API batch analysis of 1 cgmp lot NSC 750393, analysis of anti-cancer chemical &… HHSN26100002 National Cancer Institute (NIH) $7,205
Administrative costs - contract orientation and kick off meeting -analysis of anti-cancer chemical & pharm formulations… HHSN26100001 National Cancer Institute (NIH) $1,236

Transactions

Action Obligated Date
Other Administrative Action P00001 · Analysis of anti-cancer chemicals and pharmaceutical formulations. POP: 08/01/2017 - 07/31/2022. $0
Original award $0

Quick answers

Who was awarded contract HHSN261201700011I?

HHSN261201700011I was awarded to Mriglobal by National Cancer Institute (National Institutes of Health) on July 31, 2017.

How much is contract HHSN261201700011I worth?

Orders under HHSN261201700011I have obligated $133,865. HHSN261201700011I's own ceiling is $5,000,000.

How many orders have been placed under contract HHSN261201700011I?

5 orders have been placed under HHSN261201700011I, the latest on February 16, 2022.

Who can order from contract HHSN261201700011I?

HHSN261201700011I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201700011I part of a contract vehicle?

Yes. HHSN261201700011I is part of NIH Analysis of Anti-Cancer Chemicals 2017-2022.

Was contract HHSN261201700011I competed?

The extent of competition for HHSN261201700011I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login